Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

235.75  -0.05 (-0.02%)

Fundamental Rating

7

Overall 33L gets a fundamental rating of 7 out of 10. We evaluated 33L against 40 industry peers in the Textiles, Apparel & Luxury Goods industry. 33L gets an excellent profitability rating and is at the same time showing great financial health properties. 33L is valued quite expensively, but it does show have an excellent growth rating. This makes 33L very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

33L's Return On Assets of 23.87% is amongst the best of the industry. 33L outperforms 100.00% of its industry peers.
The Return On Equity of 33L (41.97%) is better than 95.00% of its industry peers.
33L's Return On Invested Capital of 30.81% is amongst the best of the industry. 33L outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 33L is significantly above the industry average of 10.85%.
The 3 year average ROIC (29.73%) for 33L is below the current ROIC(30.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.87%
ROE 41.97%
ROIC 30.81%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

33L's Profit Margin of 17.14% is amongst the best of the industry. 33L outperforms 90.00% of its industry peers.
33L's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 23.67%, 33L belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
33L's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 59.22%, 33L is in line with its industry, outperforming 42.50% of the companies in the same industry.
33L's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.67%
PM (TTM) 17.14%
GM 59.22%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

33L has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
33L has about the same amout of shares outstanding than it did 1 year ago.
33L has less shares outstanding than it did 5 years ago.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 9.50. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.50, 33L belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.5
ROIC/WACC3.62
WACC8.52%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.16 indicates that 33L has no problem at all paying its short term obligations.
33L has a Current ratio of 2.16. This is in the better half of the industry: 33L outperforms 80.00% of its industry peers.
A Quick Ratio of 1.38 indicates that 33L should not have too much problems paying its short term obligations.
33L's Quick ratio of 1.38 is amongst the best of the industry. 33L outperforms 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.38
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

7

3. Growth

3.1 Past

33L shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.02%, which is quite good.
Measured over the past years, 33L shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.37% on average per year.
Looking at the last year, 33L shows a quite strong growth in Revenue. The Revenue has grown by 10.07% in the last year.
The Revenue has been growing by 21.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)15.02%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%16.07%
Revenue 1Y (TTM)10.07%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%12.68%

3.2 Future

Based on estimates for the next years, 33L will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.54% on average per year.
33L is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.14% yearly.
EPS Next Y3.11%
EPS Next 2Y5.84%
EPS Next 3Y6.38%
EPS Next 5Y11.54%
Revenue Next Year6.34%
Revenue Next 2Y6.82%
Revenue Next 3Y6.7%
Revenue Next 5Y8.14%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.25 indicates a rather expensive valuation of 33L.
Compared to the rest of the industry, the Price/Earnings ratio of 33L is on the same level as its industry peers.
33L's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.79.
The Price/Forward Earnings ratio is 17.69, which indicates a rather expensive current valuation of 33L.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 33L indicates a somewhat cheap valuation: 33L is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. 33L is around the same levels.
Industry RankSector Rank
PE 18.25
Fwd PE 17.69
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 33L indicates a slightly more expensive valuation: 33L is more expensive than 62.50% of the companies listed in the same industry.
33L's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 33L is more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.43
EV/EBITDA 10.29
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)5.88
PEG (5Y)0.75
EPS Next 2Y5.84%
EPS Next 3Y6.38%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (4/25/2025, 7:00:00 PM)

235.75

-0.05 (-0.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)06-03 2025-06-03/amc
Inst Owners92.02%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap28.44B
Analysts76.5
Price Target351.41 (49.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.81%
Min EPS beat(2)2.91%
Max EPS beat(2)4.71%
EPS beat(4)4
Avg EPS beat(4)4.38%
Min EPS beat(4)2.91%
Max EPS beat(4)5.41%
EPS beat(8)8
Avg EPS beat(8)5.78%
EPS beat(12)11
Avg EPS beat(12)5.32%
EPS beat(16)15
Avg EPS beat(16)8.62%
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.49%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.9%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)0.61%
PT rev (1m)-10.48%
PT rev (3m)-5.24%
EPS NQ rev (1m)-5.51%
EPS NQ rev (3m)-3.46%
EPS NY rev (1m)-2.9%
EPS NY rev (3m)-1.95%
Revenue NQ rev (1m)-1.6%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE 18.25
Fwd PE 17.69
P/S 3.06
P/FCF 20.43
P/OCF 14.24
P/B 7.48
P/tB 7.79
EV/EBITDA 10.29
EPS(TTM)12.92
EY5.48%
EPS(NY)13.32
Fwd EY5.65%
FCF(TTM)11.54
FCFY4.89%
OCF(TTM)16.56
OCFY7.02%
SpS77.15
BVpS31.51
TBVpS30.26
PEG (NY)5.88
PEG (5Y)0.75
Profitability
Industry RankSector Rank
ROA 23.87%
ROE 41.97%
ROCE 43.49%
ROIC 30.81%
ROICexc 46.99%
ROICexgc 49.22%
OM 23.67%
PM (TTM) 17.14%
GM 59.22%
FCFM 14.96%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score8
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 154.35%
Cap/Sales 6.51%
Interest Coverage 5244.14
Cash Conversion 76.96%
Profit Quality 87.26%
Current Ratio 2.16
Quick Ratio 1.38
Altman-Z 9.5
F-Score8
WACC8.52%
ROIC/WACC3.62
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)15.02%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%16.07%
EPS Next Y3.11%
EPS Next 2Y5.84%
EPS Next 3Y6.38%
EPS Next 5Y11.54%
Revenue 1Y (TTM)10.07%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%12.68%
Revenue Next Year6.34%
Revenue Next 2Y6.82%
Revenue Next 3Y6.7%
Revenue Next 5Y8.14%
EBIT growth 1Y13.57%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year23.3%
EBIT Next 3Y11.41%
EBIT Next 5Y11.06%
FCF growth 1Y-3.7%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y-1.02%
OCF growth 3Y17.83%
OCF growth 5Y27.7%